TrueBlue (TBI)
(Delayed Data from NYSE)
$10.04 USD
+0.07 (0.70%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $10.03 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$10.04 USD
+0.07 (0.70%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $10.03 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
Earnings Preview: TrueBlue (TBI) Q1 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress
by Sweta Jaiswal, FRM
The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Moving Average Crossover Alert: TrueBlue
by Zacks Equity Research
TrueBlue, Inc. (TBI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
TrueBlue (TBI) Q4 Earnings Surpass Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 2.63% and -1.54%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TrueBlue (TBI) Q4 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is TrueBlue (TBI) a Profitable Pick for Value Investors?
by Zacks Equity Research
TrueBlue (TBI) stock may be a good choice for value-oriented investors right now from multiple angles.
7 Low Price-to-Sales Stocks for a Winning Portfolio in 2020
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by the company.
Are Investors Undervaluing TrueBlue (TBI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Computer Task, Quanta Services, Verso, TrueBlue and ePlus
by Zacks Equity Research
Zacks.com featured highlights include: Computer Task, Quanta Services, Verso, TrueBlue and ePlus
7 Low Price-to-Sales Stocks to Create Value-Based Returns
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
New Strong Buy Stocks for November 29th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Is TrueBlue (TBI) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: Computer Task Group, Quanta Services, AZZ, TrueBlue and ePlus
by Zacks Equity Research
Zacks.com featured highlights include: Computer Task Group, Quanta Services, AZZ, TrueBlue and ePlus
7 Value Price-to-Sales Stocks to Replenish Your Portfolio
by Rajani Lohia
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
Are Investors Undervaluing TrueBlue (TBI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: MGM Growth Properties, AZZ, Pampa Energia, TrueBlue and Green Dot
by Zacks Equity Research
Zacks.com featured highlights include: MGM Growth Properties, AZZ, Pampa Energia, TrueBlue and Green Dot
Add These 7 Value Price-to-Sales Stocks for Solid Returns
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
TrueBlue (TBI) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 15.15% and 2.45%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TrueBlue (TBI) Q3 Earnings Expected to Decline
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TrueBlue (TBI) Tops Q2 Earnings Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 10.34% and -4.07%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
TrueBlue (TBI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TrueBlue (TBI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 3.39% and 0.22%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
TrueBlue (TBI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TrueBlue (TBI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
TrueBlue (TBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.